1CMMILFF -5.81%49 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus rates MILFF with a GF Score™ of 49/100 and a GF Value™ of $0.27 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 518 Drug Manufacturers companies, 1CM ranks worse than 193050% on this metric.
1CM's yield on cost for the quarter that ended in Feb. 2026 was 0.00.
The historical rank and industry rank for 1CM's 5-Year Yield-on-Cost % or its related term are showing as below:
MILFF's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.265 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
1CM 5-Year Yield-on-Cost % Related Terms
MILFF vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1CM 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1CM's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where 1CM's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
1CM (MILFF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on 1CM and its competitors. According to the industry distribution chart, 1CM ranks #999999 out of 518 companies in the Drug Manufacturers industry.
Is 1CM's 5-Year Yield-on-Cost % too high?
1CM's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, 1CM ranks #999999 out of 518 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, 1CM has a GF Score™ of 49/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 1CM's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, 1CM ranks #999999 out of 518 companies for 5-Year Yield-on-Cost %. This places 1CM in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.27, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on 1CM and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1CM's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1CM stock overvalued right now?
Based on GuruFocus' analysis, 1CM (MILFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.27, compared to a current price of $0.07 — trading 72.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. 1CM's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For 1CM (MILFF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 1CM (MILFF) Overvalued in 2026?
Based on GuruFocus' analysis, 1CM stock appears to be undervalued.
The current stock price of $0.07 is trading 72.7% below its estimated GF Value™ of $0.27.
GuruFocus considers 1CM to be Significantly Undervalued.
Key valuation signals for MILFF:
5-Year Yield-on-Cost %: 0.00
GF Value™: $0.27 vs. price of $0.07 (72.7% below fair value)
No single metric tells the full story. See the MILFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
1CM Inc is a multi-jurisdictional cannabis company focused on its retail customers and technology to democratize cannabis markets. The Company focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions. It has a single operating segment, being Cannabis.
49GF Score
Get the complete analysis for MILFF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MILFF has been successfully added to your 